Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Pilot Trial of Angiotensin II Versus Vasopressin as Second-line Vasopressor in the Treatment of Septic Shock

NCT05193370 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT05193370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05193370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Pilot Trial of Angiotensin II Versus Vasopressin as Second-line Vasopressor in the Treatment of Septic Shock
Lead sponsor
University of New Mexico
Phase
Phase 4
Overall status
Withdrawn
Start date
January 3, 2022
Completion date
November 30, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock